Discovery of new imidazotetrazinones with potential to overcome tumor resistance. (2023)
Attributed to:
University of Nottingham CiC#6 : accelerating translation of novel, early-stage,
interdisciplinary, biomedical research
funded by
UKRI
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.ejmech.2023.115507
PubMed Identifier: 37262998
Publication URI: http://europepmc.org/abstract/MED/37262998
Type: Journal Article/Review
Volume: 257
Parent Publication: European journal of medicinal chemistry
ISSN: 0223-5234